-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on OKYO Pharma, Lowers Price Target to $5

Benzinga·07/13/2026 10:10:59
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and lowers the price target from $7 to $5.